Stocks and Investing Stocks and Investing
Thu, June 2, 2016
Wed, June 1, 2016
Tue, May 31, 2016
Fri, May 27, 2016
Thu, May 26, 2016
Wed, May 25, 2016
Tue, May 24, 2016
Mon, May 23, 2016
Fri, May 20, 2016
Thu, May 19, 2016
Wed, May 18, 2016
Tue, May 17, 2016
Mon, May 16, 2016
Fri, May 13, 2016
Thu, May 12, 2016
Wed, May 11, 2016
Tue, May 10, 2016
Mon, May 9, 2016
Fri, May 6, 2016
Thu, May 5, 2016
Wed, May 4, 2016
Tue, May 3, 2016
Mon, May 2, 2016
Sun, May 1, 2016
Fri, April 29, 2016
Thu, April 28, 2016
Wed, April 27, 2016
Tue, April 26, 2016
Mon, April 25, 2016
Fri, April 22, 2016
Thu, April 21, 2016
Wed, April 20, 2016
Tue, April 19, 2016
Mon, April 18, 2016
Sun, April 17, 2016
Fri, April 15, 2016
Thu, April 14, 2016
Wed, April 13, 2016

Joseph Schwartz Downgraded (SRPT) to Sell and Decreased Target to $5 on, May 2nd, 2016


//stocks-investing.news-articles.net/content/201 .. l-and-decreased-target-to-5-on-may-2nd-2016.html
Published in Stocks and Investing on Friday, October 25th 2024 at 12:31 GMT by WOPRAI   Print publication without navigation


Joseph Schwartz of Leerink Swann, Downgraded "Sarepta Therapeutics, Inc." (SRPT) to Sell and Decreased Target from $13 to $5 on, May 2nd, 2016.

Joseph has made no other calls on SRPT in the last 4 months.



There are 3 other peers that have a rating on SRPT. Out of the 3 peers that are also analyzing SRPT, 2 agree with Joseph's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Yun Zhong of "Janney Montgomery Scott" Initiated at Hold on, Wednesday, April 20th, 2016
  • Brian Abrahams of "RBC Capital" Downgraded from Buy to Hold and Decreased Target to $15 on, Tuesday, January 19th, 2016


This is the rating of the analyst that currently disagrees with Joseph


  • Mike Guo of "SunTrust Robinson Humphrey" Downgraded from Hold to Sell and Decreased Target to $4 on, Tuesday, April 26th, 2016

Publication Contributing Sources